SCIENSATION
The computed 12-month bankruptcy probability of SCIENSATION is 0.9% (low). The 2024 annual accounts show negative equity (€-18k) and a net result of €4k. Its solvency ranks better than 5% of 2389 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-18k |
| Net result | €4k |
| Better than sector | 5% |
| Active | 3 yrs |
Fragile profile — watch profitability in particular.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -90.0% | 63.2% | |
| Net result | €4k | €30k | |
| Equity | €-18k | €64k | |
| Gross operating margin | €7k | €49k | |
| Total assets | €20k | €121k |
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €7k |
| Net profit | €4k |
| Cash flow | €5k |
| Staff costs | — |
| Income taxes | €128 |
| Dividends | — |
| Total assets | €20k |
| Equity | €-18k |
| Debt | €39k |
| of which ≤ 1y | €39k |
| of which > 1y | — |
| Working capital | €-22k |
| Employees (FTE) | — |
| 2024 | |
|---|---|
| Current ratio | 0.43 |
| Quick ratio | 0.43 |
| Working capital ratio | -108.6% |
| Solvency | -90.0% |
| Debt / equity | -2.11 |
| Long-term debt ratio | — |
| Interest coverage | 3.39 |
| Gross margin | — |
| Net margin | — |
| ROA | 18.6% |
| ROE | -20.6% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €20k |
| Fixed assets | 21/28 | €4k |
| Tangible fixed assets | 22/27 | €4k |
| Current assets | 29/58 | €17k |
| Amounts receivable within one year | 40/41 | €4k |
| Cash & bank | 54/58 | €12k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €20k |
| Equity | 10/15 | €-18k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €-21k |
| Amounts payable | 17/49 | €39k |
| Amounts payable within one year | 42/48 | €39k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €7k |
| Operating result | 9901 | €6k |
| Financial income | 75 | €50 |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €4k |
| Income taxes | 67/77 | €128 |
| Net result for the period | 9904 | €4k |
| Result to be appropriated | 9905 | €4k |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 13-03-2023 |
| Status | Active |
| Postal code | 1410 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25764O0376/00C000 | Wallonia | 862 m² | 1 · 132 m² | 6.8 m · 2 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | SCIENSATION |